Diabetes therapy and cancer risk: where do we stand when treating patients?
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 25274656.
- Also identified by DOI 10.3949/ccjm.81a.13140.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The pathophysiology of type 2 diabetes mellitus conveys increased cancer risk, and any antidiabetic drug may alter that risk in a favorable or unfavorable way. This article discusses the links between diabetes and cancer, the different agents available for treating diabetes, and the cancer risk associated with these therapies.
Medical subject headings
- Diabetes Mellitus, Type 2
- Hypoglycemic Agents
- Neoplasms